Organon (OGN) Deferred Taxes (2020 - 2026)
Organon (OGN) posted quarterly Deferred Taxes of $16.0 million for Q2 2026, up 60.0% year-over-year from $10.0 million in Q2 2025, and up 433.33% on a QoQ basis from $3.0 million in Q1 2026.
Organon (OGN) Deferred Taxes (2020 - 2026) Analysis & Trends
Organon has reported Deferred Taxes for 7 years, with the latest figure at $16.0 million in Q2 2026.
- Deferred Taxes for Q2 2026 came in at $16.0 million, up 60.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $89.0 million (up 146.11% YoY), and the FY2025 annual result was $63.0 million, up 139.37% from the prior year.
- Deferred Taxes climbed to $16.0 million in Q2 2026, from $3.0 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $40.0 million in Q3 2025 and troughed at -$489.0 million in Q4 2023.
- A 5-year average of -$33.4 million and a median of $3.0 million in 2023 frame the typical range for Deferred Taxes.
- The largest YoY upside for Deferred Taxes was 400.0% in 2024 against a maximum downside of 2550.0% in 2024.
- A 5-year view of Deferred Taxes shows it stood at -$20.0 million in 2022, then slumped by 2345.0% to -$489.0 million in 2023, then soared by 102.04% to $10.0 million in 2024, then surged by 200.0% to $30.0 million in 2025, then sank by 46.67% to $16.0 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $16.0 million in Q2 2026, $3.0 million in Q1 2026, and $30.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.95 Bn | 632.19 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 469.97 Bn | 463.40 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 377.05 Bn | 369.90 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 302.66 Bn | 294.97 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.09 Bn | 253.19 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.99 Bn | 223.00 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 183.08 Bn | 179.90 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 160.54 Bn | 148.84 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 16.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 30.00 Mn |
| Sep 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | -17.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | -196.00 Mn |
| Jun 30, 2024 | 21.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | -489.00 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | -7.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | -20.00 Mn |
| Sep 30, 2022 | -9.00 Mn |
| Jun 30, 2022 | -5.00 Mn |
| Mar 31, 2022 | -4.00 Mn |
| Dec 31, 2021 | -76.00 Mn |
| Sep 30, 2021 | -41.00 Mn |